1.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97) Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-959251, NCI-P95-0069
2.	Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065974, NCCTG-969256, NCI-P97-0127, NCT00003170
3.	Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects Phase: Phase III Type: Supportive care Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: 06.23.CLI, NCT00455247
4.	Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
5.	Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation Phase: Phase II Type: Supportive care Status: Completed Age: 1 to 21 Sponsor: Other Protocol IDs: CDR0000067069, RPCI-RP-9810, NCI-G99-1521, NCT00003898
6.	Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: GI-05-0024, NCT00255229
7.	Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Phase: Phase II Type: Supportive care Status: Completed Age: 5 to 21 Sponsor: Other Protocol IDs: AAAA6806, CPMC-ICCR-3349, CPMC-AAAA6806, NCT00365768